Tetracycline and trimethoprim/sulfamethoxazole at clinical laboratory: Can they help to characterize Staphylococcus aureus carrying different SCCmec types?
Rev. Soc. Bras. Med. Trop
;
46(1): 100-102, Jan.-Feb. 2013. tab
Artigo
em Inglês
| LILACS
| ID: lil-666803
ABSTRACT
INTRODUCTION:
Methicillin-resistant Staphylococcus aureus (MRSA) can be difficult to detect at the clinical practice.METHODS:
We analyzed 140 MRSA isolates from inpatients to correlate the antimicrobial susceptibility with the SCCmec types.RESULTS:
Type III (n = 63) isolates were more resistant to ciprofloxacin, clindamycin, cloramphenicol, erythromycin, gentamicin, and rifampin than type IV (n = 65) ones (p < 0.05). Moreover, type IV isolates were susceptible to tetracycline (100%) and trimethoprim/sulfamethoxazole (98%), while type III isolates presented resistance to them.CONCLUSIONS:
In regions where these SCCmec types are prevalent, the detection of specific resistant phenotypes could help to predict them, mainly when there are no technical conditions to SCCmec typing.
Buscar no Google
Índice:
LILACS (Américas)
Assunto principal:
Tetraciclina
/
Combinação Trimetoprima e Sulfametoxazol
/
Farmacorresistência Bacteriana Múltipla
/
Staphylococcus aureus Resistente à Meticilina
/
Antibacterianos
Limite:
Humanos
Idioma:
Inglês
Revista:
Rev. Soc. Bras. Med. Trop
Assunto da revista:
Medicina Tropical
Ano de publicação:
2013
Tipo de documento:
Artigo
País de afiliação:
Brasil
Instituição/País de afiliação:
Universidade Federal do Rio de Janeiro/BR
Similares
MEDLINE
...
LILACS
LIS